SARAH BOWDEN: Open Payments
NPI 1962033548 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 10 payments from 8 companies in 2025. Trend: 2023 $358 · 2024 $243 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $124 |
| ABBVIE INC. | 3 | $59 |
| Merck Sharp & Dohme LLC | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Auvelity, UBRELVY, GARDASIL 9, LEQVIO, Cologuard Collection Kit, TRINTELLIX, LINZESS, REXULTI.
Industry payments across MD — which companies pay providers there.
